home / stock / pbla / pbla quote
Last: | $1.11 |
---|---|
Change Percent: | -10.81% |
Open: | $1.23 |
Close: | $1.11 |
High: | $1.28 |
Low: | $1.08 |
Volume: | 1,033,183 |
Last Trade Date Time: | 03/06/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.11 | $1.23 | $1.11 | $1.28 | $1.08 | 1,033,183 | 03-06-2024 |
$1.23 | $1.21 | $1.23 | $1.26 | $1.195 | 240,955 | 03-05-2024 |
$1.22 | $1.29 | $1.22 | $1.3 | $1.19 | 385,492 | 03-04-2024 |
$1.27 | $1.21 | $1.27 | $1.32 | $1.16 | 551,402 | 03-01-2024 |
$1.18 | $1.26 | $1.18 | $1.26 | $1.14 | 364,188 | 02-29-2024 |
$1.19 | $1.23 | $1.19 | $1.26 | $1.17 | 326,204 | 02-28-2024 |
$1.23 | $1.17 | $1.23 | $1.24 | $1.15 | 650,661 | 02-27-2024 |
$1.15 | $1.13 | $1.15 | $1.17 | $1.1 | 358,357 | 02-26-2024 |
$1.12 | $1.13 | $1.12 | $1.1396 | $1.09 | 271,397 | 02-23-2024 |
$1.11 | $1.15 | $1.11 | $1.17 | $1.1 | 327,404 | 02-22-2024 |
$1.15 | $1.2 | $1.15 | $1.2 | $1.13 | 275,994 | 02-21-2024 |
$1.18 | $1.25 | $1.18 | $1.25 | $1.15 | 577,336 | 02-20-2024 |
$1.25 | $1.26 | $1.25 | $1.31 | $1.23 | 397,308 | 02-19-2024 |
$1.25 | $1.26 | $1.25 | $1.31 | $1.23 | 397,308 | 02-16-2024 |
$1.27 | $1.4 | $1.27 | $1.41 | $1.21 | 1,293,861 | 02-15-2024 |
$1.36 | $1.13 | $1.36 | $1.5 | $1.12 | 4,031,693 | 02-14-2024 |
$1.13 | $1.17 | $1.13 | $1.17 | $1.12 | 253,517 | 02-13-2024 |
$1.17 | $1.24 | $1.17 | $1.24 | $1.145 | 506,078 | 02-12-2024 |
$1.24 | $1.14 | $1.24 | $1.26 | $1.1 | 561,811 | 02-09-2024 |
$1.14 | $1.16 | $1.14 | $1.17 | $1.08 | 360,939 | 02-08-2024 |
News, Short Squeeze, Breakout and More Instantly...
Panbela Therapeutics Inc Com Company Name:
PBLA Stock Symbol:
NASDAQ Market:
MINNEAPOLIS, April 22, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that the interim data analysis for its ...
MINNEAPOLIS, April 16, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that its common stock has been approved...
MINNEAPOLIS, March 26, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (NASDAQ:PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the...